LTZ Therapeutics

Bioscience & Disease Healthcare Systems

Website LinkedIn Beijing , Beijing , China

About LTZ Therapeutics

LTZ Therapeutics is an immunotherapy-focused global biotech startup dedicated to developing myeloid engagers for clinical trials, particularly in the fields of oncology and autoimmune diseases.

Business Information

Target Customers

healthcare providers research institutions pharmaceutical companies

Industry Categories

Bioscience & Disease Healthcare Systems

Business Model

Revenue Model Biotech licensing and partnerships

Pricing Strategy Not applicable (clinical trials)

Sales Channels direct partnerships, collaborations with research institutions

Funding Timeline

Round	Date	Amount	Investors
Series A	Apr 24, 2025	$40.0M	Unknown

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions

Minhua Chu @chuminhua432

Apr 24, 2025

🇨🇳 bio #LTZ Therapeutics announced the oversubscription and successful completion of its Series A+ #financing round, raising a total of $40 million. The newly raised funds will primarily support the Ph1 clinical trial of its lead candidate, LTZ-301 — a FIC myeloid engager https://t.co/1b2qM03BUi

View on Twitter

Similar Startups

Avammune Therapeutics

86% match

Avammune Therapeutics is a biopharmaceutical company focused on small molecule drug discovery and de...

Longbio

86% match

Longbio Pharma is a biotech startup focused on developing innovative therapies for autoimmune and ra...

Leyden Labs

85% match

Leyden Labs helps people live freely by developing products that protect from known and new respirat...

Zucara Therapeutics Inc.

85% match

A diabetes life sciences company focused on developing innovative therapies to improve the lives of ...